Skip to main content

Table 3 Health resource use during follow-up according to patient clusters

From: Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

 

Cluster 1

Cluster 2

Cluster 3

P

Cardiology visits 1Y, n (%)

2227 (75.1)

1802 (74.5)

1693 (73.3)

.34

OR [95% CI]*

1.06 [0.93–1.20]

Ref.

0.97 [0.85–1.20]

–

Internal medicine/GP visits 1Y, n (%)

1208 (51.3)

909 (46.5)

1006 (52.4)

< .001

OR [95% CI]*

1.24 [1.10–1.40]

Ref.

1.30 [1.14–1.48]

–

ER admissions 1Y, n (%)

494 (17.1)

390 (16.7)

490 (21.9)

< .001

OR [95% CI]*

1.08 [0.93–1.26]

Ref.

1.50 [1.29–1.75]

–

Cardiology visits 2Y, n (%)

1788 (68.9)

1442 (68.2)

1355 (68.6)

.88

OR [95% CI]*

1.03 [0.91–1.17]

Ref.

1.00 [0.88–1.15]

–

Internal medicine/GP visits 2Y, n (%)

1124 (51.0)

808 (45.5)

876 (51.2)

.001

OR [95% CI]*

1.27 [1.18–1.44]

Ref.

1.29 [1.13–1.48]

–

ER admissions 2Y, n (%)

352 (14.1)

287 (14.0)

297 (15.7)

.25

OR [95% CI]*

1.02 [0.86–1.21]

Ref.

1.16 [0.97–1.39]

–

  1. Legend: *adjusted for type of AF, EHRA score, use of OAC; 1Y 1 year follow-up, 2Y 2 years follow-up, CI confidence interval, ER emergency room, GP general practitioner, OR odds ratio. For other acronyms, please see previous tables’ legends